Fosun Pharma's parent company pledges more shares

Shanghai Fosun Pharmaceutical Group (SSE:600196) announced that its controlling shareholder, Fosun High Technology, has pledged an additional 30,000,000 A-shares, representing 3.12% of Fosun High Technology's holdings and 1.12% of Fosun Pharma's total shares. Following this transaction, Fosun High Technology's total pledged shares in Fosun Pharma amount to 711,300,000 A-shares, or 26.63% of Fosun Pharma's total share capital. Together with its affiliated parties, Fosun High Technology's total pledged shares are 73.50%. The pledge is for debt repayment purposes and is valid until May 22, 2027. Fosun High Technology's business operations remain normal, and it possesses the financial capacity to repay its debts. Approximately 472,342,500 shares have to be repurchased in one year (valued at CNY 38.16 billion), in which 301,492,500 shares are set to be repurchased in six months (valued at CNY 23.46 billion).